Page 15 - ESG Monograph 34-1 (Final)_Neat

National, regional, state and selected local area vaccination
coverage amongst adolescents aged 13-17 years- United States,
2015. Morbidity and Mortality Weekly Report, 65(33), 850-858.
Reiter, P. L., Stubbs, B., Panozzo, C. A., Whitesell, D., &
Brewer, N. T. (2011). HPV and HPV vaccine education
intervention: Effects on parents, healthcare staff, and school staff.
Cancer Epidemiology, Biomarkers & Prevention, 20(11), 2354-
2361. doi:10.1158/1055-9965.EPI-11-0562
Rosen, B and Goodson, P. (2013). A recommendation to use
the Diffusion of Innovations theory to understand school nurses’
role in HPV vaccine uptake. International Quarterly of
Community Health Education, 34(1), 37-49. doi:
10.2190/IQ.34.1.d
Rosen, B.L., Goodson, P., Thompson, B., & Wilson, K.L.
(2015). School nurses’ knowledge, attitudes, perceptions, and
professional practice regarding HPV vaccine for youth. Journal
of School Health, 85, 73–81. doi: 10.1111/josh.12229
Rosen, B.L., Ashwood, D., & Richardson, G.B. (2016).
School nurses’ professional practice in the HPV vaccine decision
making process. The Journal of School Nursing, 32(2), 138-48.
doi: 10.1177/1059840515583312
Salmon, D. A., Moulton, L. H., Omer, S. B., Chance, S. M.,
Klassen, A., Talebian, P.,… Halsey, N. A. (2004). Knowledge,
attitudes, and beliefs of school nurses and personnel and
associations with nonmedical immunization exemptions.
Pediatrics, 113(6), e552-e559.

Saraiya, M., Rosser, J. I., & Cooper, C. P. (2012). Cancers
U.S. Physicians Believe the HPV Vaccine Prevents:
Findings from a Physician Survey, 2009. Journal of Women’s
Health, 21(2), 111-117. doi: 10.1089/jwh.2011.3313

Stokley, S., Curtis, C. R., Jeyarajah, J., Harrington, T., Gee,
J., & Markowitz, L. E. (2013). Human papillomavirus vaccination
coverage among adolescent girls, 2007–2012, and post-licensure
vaccine safety monitoring, 2006–2013-United States. Morbidity
and Mortality Weekly Report, 62(29), 591-595.
United States Department of Health and Human Services.
(2016a). June 8, 2006 approval letter human papillomavirus
quadrivalent (Types 6,11,16,18) vaccine, recombinant. Retrieved
from
https://www.fda.gov/biologicsbloodvaccines/vaccines/approved
products/ucm111283.htm
United States Department of Health and Human Services.
(2016b). October 16, 2009 Approval letter-gardasil. Retrieved
from
http://www.fda.gov/biologicsbloodvaccines/vaccines/approvedp
roducts/ucm186991.htm
Vadaparampil, S. T., Murphy, D., Rodriguez, M., Malo, T.
L., & Quinn, G. P. (2013). Qualitative responses to a national
physician survey on HPV vaccination. Vaccine, 31(18), 2267-
2272. doi: 10.1016/j.vaccine.2013.02.063

THE HEALTH EDUCATION MONOGRAPH SERIES, Volume 34, Number 1, 2017 7